Health-related quality of life in patients with fully resected BRAFV600 mutation-positive melanoma receiving adjuvant vemurafenib.
暂无分享,去创建一个
D. Schadendorf | P. Ascierto | P. Rutkowski | L. Demidov | K. Lewis | A. Mackiewicz | A. Guminski | I. Bondarenko | B. Simmons | B. Merelli | A. Hong | C. Herbert | C. Ye | G. Goodman | A. D. Di Giacomo